Opdualag 240 mg/80 mg concentrate for solution for infusion

Company
Bristol-Myers Squibb Pharma EEIG
Active Ingredient
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed

Loading the document

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Telephone
+3531800749749
Email
medical.information@bms.com